Osaka, Rie <br/><br/>
Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections.  [electronic resource] 

 -  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde  2018 
 - 27-35 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1423-0267 
<br/><br/><label>Standard No.: </label>10.1159/000479049  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Fluorescein Angiography<br/>Follow-Up Studies<br/>Fundus Oculi<br/>Humans<br/>Intravitreal Injections<br/>Macula Lutea--pathology<br/>Macular Edema--diagnosis<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Ranibizumab--administration & dosage<br/>Retinal Vein Occlusion--complications<br/>Time Factors<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity